HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

474.400

-6.600-1.37%

Volume:736.29K

Turnover:348.70M

Market Cap:113.38B

PE:-245.19

High:481.600

Open:481.000

Low:467.400

Close:481.000

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:1.87

T/O Rate:0.42%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.935

ROE:2.92%

ROA:0.03%

PB:18.19

PE(LYR):-245.19

PS:46.55

Loading ...

Overview Company News Filings

Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint

MT Newswires Live

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC

Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment

SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial

Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC

Bulletin Express

Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC

Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab

THOMSON REUTERS

GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT

Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues

Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement

SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing

Bulletin Express

SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%

Bulletin Express

SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express

Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing

Kelun-biotech Completes Hk$2.72 Billion H-share Placement at Hk$470.2 Per Share

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement

MT Newswires Live

SKB BIO Announces Share Placement at Discount, Aiming to Raise Approximately HK$2.72 Billion

Sichuan Kelun-biotech Prices 5,838,000-share H-share Placement at HK$ 470.2

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/06990/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":474.4,"timestamp":1789027724006,"preClose":481,"halted":0,"volume":736288,"delay":0,"changeRate":-0.013721413721413769,"floatShares":177000000,"shares":239000000,"eps":-1.9348457647759978,"marketStatus":"Not Yet Opened","change":-6.6,"latestTime":"09-10 16:08:44","open":481,"high":481.6,"low":467.4,"amount":348698217,"amplitude":0.029522,"askPrice":474.4,"askSize":800,"bidPrice":473.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.7569935306184864,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":481,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.865917348291155,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.934846,"volumeRatio":1.865917348291155,"shares":239000000,"dividePrice":0,"high":481.6,"amplitude":0.029522,"preClose":481,"low":467.4,"week52Low":339.6,"pbRate":"18.19","psRate":"46.55","week52High":581,"institutionHeld":0,"latestPrice":474.4,"committee":-0.777778,"eps":-1.9348457647759978,"divideRate":0,"volume":736288,"delay":0,"ttmEps":0.7569935306184864,"open":481,"prevYearClose":392.2,"prevWeekClose":489.4,"prevMonthClose":497.2,"prevQuarterClose":436.2,"fiveDayClose":496.8,"twentyDayClose":525.5,"sixtyDayClose":425.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4091,"buy":0.5909,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5909,"analysts":22,"updateTime":1786636800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-09-09","current":626.689636,"percent":0.979487,"low":-351.800852,"twenty":-235.76357,"median":-134.316183,"eighty":-51.156498,"high":737.230287,"avg":-123.74326,"sd":146.803985,"marketCap":114970529089},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322},{"date":"2026-08-28","current":697.321291,"twenty":-236.422847,"median":-135.694724,"eighty":-52.683151,"marketCap":122977832050},{"date":"2026-09-04","current":663.036146,"twenty":-235.974841,"median":-134.724854,"eighty":-51.598494,"marketCap":116978330428},{"date":"2026-09-09","current":650.614565,"twenty":-235.76357,"median":-134.316183,"eighty":-51.156498,"marketCap":114970529089}],"updateTime":1789072426486},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651436131","title":"Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436131","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436131?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:46","pubTimestamp":1784087219,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical's  phase 3 study of sacituzumab tirumotecan  combined with Merck's Keytruda met the primary endpoint in first-line treatment of PD-L1-negative advanced non-squamous non-small cell lung cancer, according to a Wednesday Hong Kong bourse filing.The study showed the combination significantly improved progression-free survival compared with pembrolizumab plus chemotherapy.An interim analysis also indicated a positive trend in overall survival, while no new safety signals were identified.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK1161","BK4585","XBI","BK4581","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101227446","title":"Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access","url":"https://stock-news.laohu8.com/highlight/detail?id=1101227446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101227446?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:56","pubTimestamp":1784084190,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies are leading gains in the Hong Kong market.SKB BIO (06990) rose 10.5% to HK$550.5, while INNOVENT BIO (01801) gained 8.38% to HK$97.6. AKESO (09926) advanced 7.88%...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","159992","LU0502904849.HKD","LU0348827113.USD","LU0348783233.USD","LU0540923850.HKD","LU0196878994.USD","LU1720050803.USD","LU2097828474.EUR","01801","09926","LU0348766576.USD","LU0348735423.USD","LU2476274308.USD","LU2097828805.USD","LU1969619763.USD","LU0634319403.HKD","06978","BK1589","IBBQ","LU1794554557.SGD","MEDX","01530","LU2328871848.SGD","BK4585","LU2097828631.EUR","HK0000165453.HKD","LU0561508036.HKD","KURE","VXUS","LU2242644610.SGD","IE00B543WZ88.USD","LU1961090484.USD","BK1574","LU0417516902.SGD","LU2488822045.USD","LU2476274720.SGD","BK1593","IE00B5MMRT66.SGD","BK1583","LU0348825331.USD","LU2097828557.USD","LU2399975544.HKD","BK1161","BK4588","LU2097828714.EUR","KCAI","LU0417516738.SGD","LU0455707207.USD","LU2778985437.USD","LU0417516571.SGD","IE00BPRC5H50.USD","06990","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102600985","title":"Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1102600985","media":"Market Focus","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102600985?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:39","pubTimestamp":1784083181,"startTime":"0","endTime":"0","summary":"On July 15, Kelun-Biotech (06990.HK) rose 10.8% in regular trading to HK$552.0, with turnover of HK$465 million.The rally was driven by the company announcing that its core product sacituzumab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480077","title":"Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480077","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480077?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:20","pubTimestamp":1784078400,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharma Says Primary Endpoint Met For Phase 3 Study Of Lung Cancer TreatmentJuly 15 (Reuters)-Sichuan Kelun-Biotech Biopharmaceutical Co Ltd6990.HK:PRIMARY ENDPOINT MET F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197384924","title":"SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1197384924","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197384924?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:44","pubTimestamp":1784072678,"startTime":"0","endTime":"0","summary":"SKB BIO (ASX: 06990) has announced that its Phase 3 clinical trial for the combination therapy of its core TROP2-targeting antibody-drug conjugate (ADC), sac-TMT (also known as SKB264/MK-2870), with...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK1161","LU0196878994.USD","LU1169589451.USD","PD","LU1169590202.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119756156","title":"Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1119756156","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119756156?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:40","pubTimestamp":1784072440,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) announced that an Independent Data Monitoring Committee has confirmed the Phase 3 OptiTROP-Lung06 trial met its primary endpoint. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482461","title":"Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482461","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482461?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:24","pubTimestamp":1784071455,"startTime":"0","endTime":"0","summary":"Kelun-Biotech says Phase 3 sac-TMT plus Keytruda meets PFS endpoint in first-line PD-L1-negative NSCLCSichuan Kelun-Biotech reported its Phase 3 OptiTROP-Lung06 study met the primary endpoint of progr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLbLHStv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651431482","title":"Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2651431482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651431482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:23","pubTimestamp":1784071412,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143660492","title":"GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT","url":"https://stock-news.laohu8.com/highlight/detail?id=1143660492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143660492?lang=en_us&edition=fundamental","pubTime":"2026-07-14 15:30","pubTimestamp":1784014245,"startTime":"0","endTime":"0","summary":"A recent report from GLMS SEC highlights that substantial opportunities for advancement remain in the first-line treatment of advanced lung cancer. This is due to limited survival benefits for many...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2279701549.SGD","LU0890818403.SGD","LU1655091616.SGD","IE00B543WZ88.USD","LU0593848301.USD","IE0008369823.USD","BK0276","BK1161","BK1564","LU0431992006.USD","BK1607","601456","01456","IE00BZ08YT58.USD","LU2778985437.USD","LU1115378108.SGD","LU0877626530.USD","IE00B29SXG58.USD","IE00BZ08YS42.EUR","LU0868486357.SGD","IE00BZ08YR35.GBP","LU2476274308.USD","LU0196878994.USD","LU0205439572.USD","LU1119993845.HKD","IE0034224299.USD","IE00B5MMRT66.SGD","LU0862451753.SGD","BK1147","IE00B031HY20.USD","BK1214","LU2048586759.USD","161027","IE0008368742.USD","06690","IE00BPRC5H50.USD","LU0640798160.USD","06990","IE00BYV24P56.USD","IE00BMCWC346.EUR","BK1557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152270577","title":"Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1152270577","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152270577?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:05","pubTimestamp":1783994702,"startTime":"0","endTime":"0","summary":"On July 14, Kelun-Biotech fell 3.17% in regular trading, trading at HK$500.5/share, with turnover of HK$135 million.On the news front, the company completed a placement of 5.838 million new H shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128287343","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=1128287343","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128287343?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:47","pubTimestamp":1783907233,"startTime":"0","endTime":"0","summary":"On July 13, Kelun-Biotech Biopharmaceutical fell 3.1% in regular trading, trading at HK$489.2/share, with turnover of HK$208 million. The decline represents a technical correction following a sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109702331","title":"SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1109702331","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109702331?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675372,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has published its revised Articles of Association, now effective after the company’s 11 July 2023 debut on the Hong Kong Stock Exchange...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173568073","title":"SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173568073","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173568073?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675346,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has closed its previously announced H-share placement, issuing 5.84 million new shares at HK$470.20 each. All terms under the placing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180080507","title":"SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180080507","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180080507?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675345,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026. The shares were issued at HKD 470.20 each,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650540186","title":"Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2650540186","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650540186?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:20","pubTimestamp":1783675234,"startTime":"0","endTime":"0","summary":"Kelun-Biotech files HKEX next-day disclosure return, share capital rises on 5,838,000 new H shares placingSichuan Kelun-Biotech filed a next day disclosure return on July 10, 2026 following completion","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLbCgPLZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002422","LU1064130708.USD","LU0196878994.USD","BK0239","LU2148510915.USD","06990","LU1064131003.USD","LU1979443071.USD","BK1161","BK0060","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650186380","title":"Kelun-biotech Completes Hk$2.72 Billion H-share Placement at Hk$470.2 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2650186380","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650186380?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:17","pubTimestamp":1783675038,"startTime":"0","endTime":"0","summary":"Kelun-Biotech completes HK$2.72 billion H-share placement at HK$470.2 per shareSichuan Kelun-Biotech Biopharmaceutical completed a private placement of 5,838,000 new H shares on July 10, 2026.Shares priced at HK$ 470.2 each; net proceeds about HK$ 2.72 billion.Proceeds earmarked mainly for R&D and clinical development, with smaller allocations for pipeline expansion and working capital.Total shares outstanding rose to 239,023,969; Kelun Pharmaceutical stake diluted to 62.53% from 64.1%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on July","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL9tS7Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2148510915.USD","LU1934453819.USD","LU1064130708.USD","BK1161","BK0060","002422","LU0196878994.USD","LU1064131003.USD","LU1979443071.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191809569","title":"Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=1191809569","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191809569?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:28","pubTimestamp":1783650507,"startTime":"0","endTime":"0","summary":"Shares of innovative drug concept stocks are leading gains in the Hong Kong market.At the time of writing, SKB BIO (06990) is up 6% to HK$503.5, while REMEGEN (09995) has risen 6.04% to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU2097828714.EUR","BK1583","01672","LU1969619763.USD","LU0502904849.HKD","LU2328871848.SGD","KCAI","BK1574","LU2097828631.EUR","LU2097828474.EUR","LU0455707207.USD","LU2242644610.SGD","BK4585","BK1515","159992","LU0196878994.USD","LU2488822045.USD","BK4588","MEDX","VXUS","KURE","HK0000165453.HKD","09995","06978","LU2097828557.USD","01801","IBBQ","LU2097828805.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649951096","title":"Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2649951096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649951096?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:33","pubTimestamp":1783478020,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical  is looking to raise estimated net proceeds of about HK$2.72 billion through a share placement, according to a Hong Kong bourse filing Wednesday.The drugmaker is placing 5.84 million new H-shares at HK$470.20 each.The net proceeds will be used for research and development, clinical trials, registration filings, manufacturing and commercialization of its products, expansion of its research and development capabilities and product pipeline, and working capital and general corporate purposes.The shares represent about 2.50% of the company's existing issued share capital and about 2.44% of its enlarged share capital after the placement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK1161","LU0196878994.USD","BK4585","XBI","BK4588","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105799642","title":"SKB BIO Announces Share Placement at Discount, Aiming to Raise Approximately HK$2.72 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1105799642","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105799642?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:55","pubTimestamp":1783464914,"startTime":"0","endTime":"0","summary":"SKB BIO has entered into a share placement agreement, the company announced.Under the terms of the agreement, which was signed on July 8, 2026, before market hours, the placement agent has...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649533259","title":"Sichuan Kelun-biotech Prices 5,838,000-share H-share Placement at HK$ 470.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2649533259","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649533259?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:22","pubTimestamp":1783462979,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech prices 5,838,000-share H-share placement at HK$ 470.2Sichuan Kelun-Biotech Biopharmaceutical agreed a private placement of 5,838,000 new H shares at HK$ 470.2 each.Net proceeds e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8VMwxR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","IE0002270589.USD","LU2236285917.USD","LU0162691827.USD","LU2237438978.USD","BK4127","LU2237443465.HKD","FTXO","LU2237443978.SGD","BK1161","LU0251131958.USD","BK0239","LU0203345920.USD","LU1868836591.USD","GSX","LU1064131003.USD","BK4533","LU1244550577.SGD","IE0004091025.USD","IE00BSNM7G36.USD","LU2237443549.SGD","LU0072461881.USD","LU1979443071.USD","LU2471134523.USD","LU0052756011.USD","LU2471134879.HKD","LU0048573561.USD","LU2237443382.USD","002422","LU2471134796.USD","LU0742534661.SGD","LU2125154778.USD","LU2750360997.AUD","LU0251142724.SGD","BK4585","BK4516","06990","LU0170899867.USD","LU1201861249.SGD","LU1162221912.USD","IE00B19Z3581.USD","LU2456880835.USD","IYF","LU0648001328.SGD","LU0477156953.USD","LU0130517989.USD","LU1894683264.USD","LU2750360641.GBP","BK4534","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}